Guimarães, Rayanne Poletti; Ribeiro, Danilo Leandro 
; Santos, Keila Dayane Bariotto dos; Talarico, Carlos Henrique Zanello; Godoy, Lívea Dornela; Padovan Neto, Fernando Eduardo
Source: Pharmaceuticals. Unidades: FFCLRP, FMRP
Subjects: DISCINESIAS, DOENÇA DE PARKINSON, NEURÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Rayanne Poletti et al. Phosphodiesterase 10A inhibition modulates the corticostriatal activity and L-DOPA-induced dyskinesia. Pharmaceuticals, v. 15, n. 8, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.3390/ph15080947. Acesso em: 21 abr. 2026.APA
Guimarães, R. P., Ribeiro, D. L., Santos, K. D. B. dos, Talarico, C. H. Z., Godoy, L. D., & Padovan Neto, F. E. (2022). Phosphodiesterase 10A inhibition modulates the corticostriatal activity and L-DOPA-induced dyskinesia. Pharmaceuticals, 15( 8), 1-20. doi:10.3390/ph15080947NLM
Guimarães RP, Ribeiro DL, Santos KDB dos, Talarico CHZ, Godoy LD, Padovan Neto FE. Phosphodiesterase 10A inhibition modulates the corticostriatal activity and L-DOPA-induced dyskinesia [Internet]. Pharmaceuticals. 2022 ; 15( 8): 1-20.[citado 2026 abr. 21 ] Available from: https://doi.org/10.3390/ph15080947Vancouver
Guimarães RP, Ribeiro DL, Santos KDB dos, Talarico CHZ, Godoy LD, Padovan Neto FE. Phosphodiesterase 10A inhibition modulates the corticostriatal activity and L-DOPA-induced dyskinesia [Internet]. Pharmaceuticals. 2022 ; 15( 8): 1-20.[citado 2026 abr. 21 ] Available from: https://doi.org/10.3390/ph15080947
